A Multicenter, Randomized, Double-blind, Crossover Study to Assess the Injection Site Pain Associated With a Modified Etanercept Formulation in Adult Subjects With Either Rheumatoid Arthritis or Psoriatic Arthritis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 19 Sep 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Amgen
- 14 Sep 2017 Planned End Date changed from 18 Oct 2017 to 9 Oct 2017.
- 14 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Jun 2017 Trial phase has been change from phase 4 to phase 3 .